XML 95 R53.htm IDEA: XBRL DOCUMENT v3.19.3
Offsetting of Assets and Liabilities (Tables)
 9 Months Ended
Sep. 30, 2019
Offsetting of Assets and Liabilities [Abstract]  
Schedule of Offsetting of Assets and Liabilities
The following table presents information about certain assets and liabilities representing financial instruments as of September 30, 2019. The Company has not entered into master netting agreements with any of its counterparties. Certain of the Company's reverse repurchase and repurchase agreements and financial derivative transactions are governed by underlying agreements that generally provide a right of offset in the event of default or in the event of a bankruptcy of either party to the transaction.
September 30, 2019:
Description
 
Amount of Assets (Liabilities) Presented in the Condensed Consolidated Balance Sheet(1)
 
Financial Instruments Available for Offset
 
Financial Instruments Transferred or Pledged as Collateral(2)(3)
 
Cash Collateral (Received) Pledged(2)(3)
 
Net Amount
(In thousands)
 
 
 
 
 
 
 
 
 
 
Assets
 
 
 
 
 
 
 
 
 
 
Financial derivatives–assets
 
$
12,740

 
$
(9,531
)
 
$
—

 
$
(1,217
)
 
$
1,992

Reverse repurchase agreements
 
36,473

 
(36,473
)
 
—

 
—

 
—

Liabilities
 
 
 
 
 
 
 
 
 
 
Financial derivatives–liabilities
 
(25,572
)
 
9,531

 
—

 
13,640

 
(2,401
)
Repurchase agreements
 
(2,056,422
)
 
36,473

 
2,002,235

 
17,714

 
—

(1)
In the Company's Condensed Consolidated Balance Sheet, all balances associated with repurchase agreements, reverse repurchase agreements, and financial derivatives are presented on a gross basis.
(2)
For the purpose of this presentation, for each row the total amount of financial instruments transferred or pledged and cash collateral (received) or pledged may not exceed the applicable gross amount of assets or (liabilities) as presented here. Therefore, the Company has reduced the amount of financial instruments transferred or pledged as collateral related to the Company's reverse repurchase agreements and cash collateral pledged on the Company's financial derivative liabilities. Total financial instruments transferred or pledged as collateral on the Company's reverse repurchase agreements as of September 30, 2019 was $2.19 billion. As of September 30, 2019, total cash collateral on financial derivative assets and liabilities excludes excess net cash collateral pledged of $3.7 million and $21.0 million, respectively.
(3)
When collateral is pledged to or pledged by a counterparty, it is often pledged or posted with respect to all positions with such counterparty, and in such cases such collateral cannot be specifically identified as relating to a specific asset or liability. As a result, in preparing the above tables, the Company has made assumptions in allocating pledged or posted collateral among the various rows.
The following tables present information about certain assets and liabilities representing financial instruments as of December 31, 2018. The Company has not entered into master netting agreements with any of its counterparties. Certain of the Company's repurchase and reverse repurchase agreements and financial derivative transactions are governed by underlying agreements that generally provide a right of offset in the event of default or in the event of a bankruptcy of either party to the transaction.
December 31, 2018:
Description
 
Amount of Assets (Liabilities) Presented in the Consolidated Statements of Assets, Liabilities, and Equity(1)
 
Financial Instruments Available for Offset
 
Financial Instruments Transferred or Pledged as Collateral(2)(3)
 
Cash Collateral (Received) Pledged(2)(3)
 
Net Amount
(In thousands)
 
 
 
 
 
 
 
 
 
 
Assets
 
 
 
 
 
 
 
 
 
 
Financial derivatives–assets
 
$
20,001

 
$
(10,910
)
 
$
—

 
$
(2,514
)
 
$
6,577

Repurchase agreements
 
61,274

 
(61,274
)
 
—

 
—

 
—

Liabilities
 
 
 
 
 

 
 
 
 
Financial derivatives–liabilities
 
(20,806
)
 
10,910

 
—

 
9,896

 
—

Reverse repurchase agreements
 
(1,498,849
)
 
61,274

 
1,420,601

 
16,974

 
—

(1)
In the Company's Consolidated Statement of Assets, Liabilities, and Equity, all balances associated with repurchase agreements, reverse repurchase agreements, and financial derivatives are presented on a gross basis.
(2)
For the purpose of this presentation, for each row the total amount of financial instruments transferred or pledged and cash collateral (received) or pledged may not exceed the applicable gross amount of assets or (liabilities) as presented here. Therefore, the Company has reduced the amount of financial instruments transferred or pledged as collateral related to the Company's reverse repurchase agreements and cash collateral pledged on the Company's financial derivative liabilities. Total financial instruments transferred or pledged as collateral on the Company's reverse repurchase agreements as of December 31, 2018 were $1.79 billion. As of December 31, 2018 total cash collateral on financial derivative assets excludes excess net cash collateral pledged of $0.1 million. As of December 31, 2018 total cash collateral on financial derivative liabilities excludes excess cash collateral pledged of $16.4 million.
(3)
When collateral is pledged to or pledged by a counterparty, it is often pledged or posted with respect to all positions with such counterparty, and in such cases such collateral cannot be specifically identified as relating to a specific asset or liability. As a result, in preparing the above tables, the Company has made assumptions in allocating pledged or posted collateral among the various rows.